Baba Inusa

4.6k total citations
117 papers, 1.9k citations indexed

About

Baba Inusa is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Baba Inusa has authored 117 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Genetics, 79 papers in Hematology and 30 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Baba Inusa's work include Hemoglobinopathies and Related Disorders (108 papers), Iron Metabolism and Disorders (72 papers) and Blood groups and transfusion (19 papers). Baba Inusa is often cited by papers focused on Hemoglobinopathies and Related Disorders (108 papers), Iron Metabolism and Disorders (72 papers) and Blood groups and transfusion (19 papers). Baba Inusa collaborates with scholars based in United Kingdom, United States and Italy. Baba Inusa's co-authors include Stephen Obaro, Catherine Booth, Fenella J. Kirkham, David C. Rees, Michael R. DeBaun, Jo Howard, Kofi A. Anie, Wale Atoyebi, Lewis L. Hsu and Mark Rodeghier and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Baba Inusa

110 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Baba Inusa 1.5k 1.2k 459 171 141 117 1.9k
Banu Aygün 2.1k 1.4× 1.9k 1.6× 644 1.4× 373 2.2× 151 1.1× 114 2.8k
Dianne Gallagher 1.7k 1.1× 1.4k 1.2× 595 1.3× 134 0.8× 47 0.3× 24 2.1k
Doris L. Wethers 2.3k 1.5× 1.8k 1.5× 749 1.6× 192 1.1× 90 0.6× 23 2.7k
Vincenzo De Sanctis 1.2k 0.8× 984 0.8× 387 0.8× 74 0.4× 41 0.3× 63 1.6k
Jude Jonassaint 1.1k 0.7× 820 0.7× 249 0.5× 154 0.9× 80 0.6× 48 1.5k
Patricia Adams‐Graves 967 0.6× 673 0.6× 362 0.8× 112 0.7× 41 0.3× 27 1.2k
Lennette J. Benjamin 943 0.6× 638 0.5× 324 0.7× 127 0.7× 34 0.2× 22 1.2k
Subarna Chakravorty 690 0.5× 615 0.5× 328 0.7× 45 0.3× 79 0.6× 61 965
Giorgos Chouliaras 434 0.3× 408 0.3× 177 0.4× 77 0.5× 41 0.3× 52 1.3k
Dorothy Tatter 244 0.2× 183 0.2× 202 0.4× 67 0.4× 36 0.3× 26 1.4k

Countries citing papers authored by Baba Inusa

Since Specialization
Citations

This map shows the geographic impact of Baba Inusa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baba Inusa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baba Inusa more than expected).

Fields of papers citing papers by Baba Inusa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baba Inusa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baba Inusa. The network helps show where Baba Inusa may publish in the future.

Co-authorship network of co-authors of Baba Inusa

This figure shows the co-authorship network connecting the top 25 collaborators of Baba Inusa. A scholar is included among the top collaborators of Baba Inusa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baba Inusa. Baba Inusa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Montalembert, Mariane de, Fernando Ferreira Costa, Baba Inusa, et al.. (2024). Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: Perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease. European Journal Of Haematology. 113(2). 172–182. 2 indexed citations
3.
Rankine‐Mullings, Angela, Russell Keenan, Subarna Chakravorty, et al.. (2023). Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia. Blood Advances. 7(16). 4319–4322. 5 indexed citations
4.
Hamdy, Mona, Amal El‐Beshlawy, Julie Kanter, et al.. (2023). Deferiprone versus deferoxamine for transfusional iron overload in sickle cell disease and other anemias: Pediatric subgroup analysis of the randomized, open‐label FIRST study. Pediatric Blood & Cancer. 71(1). e30711–e30711. 4 indexed citations
5.
Inusa, Baba, et al.. (2023). Global burden of transfusion in sickle cell disease. Transfusion and Apheresis Science. 62(5). 103764–103764. 6 indexed citations
6.
Elalfy, Mohsen Saleh, Mona Hamdy, Amal El‐Beshlawy, et al.. (2022). Deferiprone for transfusional iron overload in sickle cell disease and other anemias: open-label study of up to 3 years. Blood Advances. 7(4). 611–619. 16 indexed citations
7.
Estepp, Jeremie H., Ram Kalpatthi, Gerald M. Woods, et al.. (2022). Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. Pediatric Blood & Cancer. 69(8). e29716–e29716. 31 indexed citations
8.
Heeney, Matthew M., Miguel R. Abboud, Jessie Githanga, et al.. (2022). Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study. Blood. 140(13). 1470–1481. 11 indexed citations
9.
Kwiatkowski, Janet L., Mona Hamdy, Amal El‐Beshlawy, et al.. (2021). Deferiprone vs deferoxamine for transfusional iron overload in SCD and other anemias: a randomized, open-label noninferiority study. Blood Advances. 6(4). 1243–1254. 33 indexed citations
10.
Cuzzubbo, Daniela, Maddalena Casale, Corrina McMahon, et al.. (2021). Limited Access to Transcranial Doppler Screening and Stroke Prevention for Children with Sickle Cell Disease in Europe: Results of a Multinational Eurobloodnet Survey. Blood. 138(Supplement 1). 915–915. 1 indexed citations
11.
Brewin, John, Alexander Smith, Sanjay Tewari, et al.. (2020). Genetic Analysis of Patients With Sickle Cell Anemia and Stroke Before 4 Years of Age Suggest an Important Role for Apoliprotein E. Circulation Genomic and Precision Medicine. 13(5). 531–540. 8 indexed citations
12.
Inusa, Baba, et al.. (2020). COVID‐19 and the pulmonary complications of sickle cell disease. SHILAP Revista de lepidopterología. 1(2). 545–547. 13 indexed citations
13.
Liguoro, Ilaria, Michele Arigliani, Subarna Chakravorty, et al.. (2020). Beneficial effects of adenotonsillectomy in children with sickle cell disease. ERJ Open Research. 6(4). 71–2020. 4 indexed citations
14.
Inusa, Baba. (2020). Symptoms and Complications of Sickle Cell Disease Analyzed By Patient-Reported Genotype, Sex and Country/Region: Results from the International Sickle Cell World Assessment Survey (SWAY). 1 indexed citations
15.
Inusa, Baba, Laura Sainati, Raffaella Colombatti, et al.. (2019). An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective. Journal of Clinical Medicine. 9(1). 44–44. 11 indexed citations
16.
Inusa, Baba, et al.. (2019). Sickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment. International Journal of Neonatal Screening. 5(2). 20–20. 127 indexed citations
17.
18.
19.
Howard, Jo, et al.. (2010). Moving young people with sickle cell disease from paediatric to adult services. British Journal of Hospital Medicine. 71(6). 310–314. 9 indexed citations
20.
Kirkham, Fenella J., Nomazulu Dlamini, D. Saunders, et al.. (2009). Risk Factors for Stroke Recurrence in Sickle Cell Disease. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Banu Aygün Breakdown of academic impact, for papers by Dianne Gallagher Breakdown of academic impact, for papers by Doris L. Wethers Breakdown of academic impact, for papers by Vincenzo De Sanctis Breakdown of academic impact, for papers by Jude Jonassaint Breakdown of academic impact, for papers by Patricia Adams‐Graves Breakdown of academic impact, for papers by Lennette J. Benjamin Breakdown of academic impact, for papers by Subarna Chakravorty Breakdown of academic impact, for papers by Giorgos Chouliaras Breakdown of academic impact, for papers by Dorothy Tatter
Rankless by CCL
2026